For some people, depression is like an unwanted guest who moves in and refuses to leave. Even with therapy and medication, the heavy fog of low mood, exhaustion and hopelessness never fully lifts for long. For around 30% ...
May 20, 2025
0
0
Middle-aged and older adults who experience pain are more likely to have had worsening symptoms of depression up to eight years before the pain began, according to a new study by UCL researchers.
May 20, 2025
0
59
A systematic review and meta-analysis evaluated the effects of dietary interventions on depression and anxiety in adults. The review found that calorie-restrictive and low-fat diets may reduce depression symptoms in those ...
May 19, 2025
0
0
Postpartum depression (PPD) affects up to 15% of individuals after childbirth. Early identification of patients at risk of PPD could improve proactive mental health support. Mass General Brigham researchers developed a machine ...
May 19, 2025
0
0
Two new studies examining mental health risks postpartum are published online in the American Journal of Psychiatry in conjunction with Maternal Mental Health Awareness Month and the 2025 Annual Meeting of the American Psychiatric ...
May 19, 2025
0
0
A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that glucagon-like peptide 1 receptor agonists (GLP1-RAs)—a class of medications used to treat ...
May 19, 2025
0
128
Talking therapy for patients with symptoms of anxiety and depression could be key to significantly reducing the risk of them developing psychosis, according to new research.
May 19, 2025
0
0
People who experience depression following a stroke may face a higher risk of poor health and even death for up to a decade afterward, new research finds.
May 16, 2025
0
22
Newborn babies with a vitamin D deficiency have a higher chance of later developing mental disorders such as ADHD, schizophrenia and autism, a major study involving the University of Queensland has found.
May 15, 2025
1
171
Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, report findings on the efficacy of fremanezumab (sold as Ajovy by Teva) in reducing migraine frequency ...
